ScaleReady

We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration

Explore how G-Rex’s gas-permeable membrane eliminates the need for media changes during cell expansion—just fill it and forget it! We’re excited to invite you to visit us at our booth(#927) at the 39th Annual SITC Meeting in Houston 🌵. Uncover our groundbreaking G-Rex bioreactors and see how they can revolutionize your cell culture processes. Our team of G-Rex Optimization Specialists will be on hand to discuss the reliable and scalable features of our devices. Don’t miss this opportunity to learn more about the innovative G-Rex! #SITC #cellandgenetherapy #celltherapy #innovation

We're excited to announce a new grant program to support the development of cell and gene therapies! Qualifying academic institutions and biotech firms can receive up to $300,000 in Wilson Wolf Manufacturing, LLC G-Rex devices, reagents, and expert support. This program aims to accelerate the path to market for life-saving therapies. Read this BioProcess International article to learn more about how we're driving innovation in CGT: https://lnkd.in/geGsSi2i #CGT #celltherapy #genetherapy #grant #biotech #pharma #scaleup

A successful contamination control strategy (CCS) is essential for cGMP compliance in CGT manufacturing. Our poster explores how G-Rex Bioreactors and Heracell Vios Incubators can empower you to establish a robust CCS and achieve superior production outcomes. Download it today: https://lnkd.in/eNhqhjix #celltherapy #genetherapy #CGT

The future of cell and gene therapy manufacturing is bright! Our Global Director, Josh Ludwig, is featured in The Medicine Maker alongside industry leaders discussing the transformative power of automation and digitalization. Learn how ScaleReady is helping to accelerate the development of life-saving therapies: https://lnkd.in/ei4uE8DT #celltherapy #genetherapy #manufacturing #automation #digitalization #medicinemaker

During Healthcare Quality Week (Oct. 20-26), we set aside time to honor healthcare workers and amplify awareness of the positive influence they bring to their organizations and communities. 🌟 A heartfelt thank you to the healthcare heroes who are making a significant difference in the lives of patients and their loved ones. Your dedication is truly appreciated! https://lnkd.in/gwGksg6k #HealthcareQualityWeek #HealthcareHeroes

Can sustainability and patient care go hand-in-hand? Absolutely! BioProcess International's recent podcats dives deep into how decentralized manufacturing can improve both with Josh Ludwig and Germfree. Want to learn more? Listen to the full episode: https://lnkd.in/gnpNKDPa #biotech #sustainability #manufacturing #cellandgenetherapy #patientcare #scaleready

Come explore the revolutionary G-Rex Bioreactors, designed for cell culture applications, at our booth in the Exhibit Hall at the Hanson Wade Group TIL Therapies Summit in Boston with the ScaleReady team. Engineered to adapt to the changing needs of immune cell therapies, G-Rex ensures reliable, effective, and scalable cell expansion. Its ability to process patients in parallel and produce significant cell quantities crucial for cell-based therapeutics across manufacturing scales marks a significant breakthrough. 🔬 Join us from October 23rd to 24th for a comprehensive look at G-Rex's innovation! https://lnkd.in/e7Dv-jmG #TILTherapies #TILTherapiesSummit #celltherapy #cellmanufacturing

Want to know what's driving innovation in cell and gene therapy? Check out this Drug Discovery World article featuring insights from industry experts, including Josh Ludwig, Global Commercial Director at ScaleReady. Read about the challenges and opportunities facing the sector: https://lnkd.in/eX-_e_rc Contact us to learn how ScaleReady is playing a crucial role in the future of cell and gene therapy. #CGT #Celltherapy #innovation

Did you know that operational efficiency is the key to a sustainable CGT future? Our Global Director, Josh Ludwig, shared valuable insights at ISCT, International Society for Cell & Gene Therapy 2024, featured in Drug Discovery World. Learn how optimizing processes can dramatically impact your bottom line and environmental footprint. https://lnkd.in/eSbjeHcy #CGT #sustainability #drugdiscovery #scaleup #biotech #pharma